Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of Select Medical Holdings Corporation (SEM)?

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The time period between June 25 and the end of October was one of those periods, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 14 percentage points. Given that the funds we track tend to have a disproportionate amount of their portfolios in smaller cap stocks, they have seen some volatility in their portfolios too. Actually their moves are potentially one of the factors that contributed to this volatility. In this article, we use our extensive database of hedge fund holdings to find out what the smart money thinks of Select Medical Holdings Corporation (NYSE:SEM).

Select Medical Holdings Corporation (NYSE:SEM) has seen an increase in support from the world’s most elite money managers in recent months. SEM was in 23 hedge funds’ portfolios at the end of September. There were 22 hedge funds in our database with SEM positions at the end of the previous quarter. At the end of this article we will also compare SEM to other stocks including Prothena Corporation PLC (NASDAQ:PRTA), Third Point Reinsurance Ltd (NYSE:TPRE), and Avon Products, Inc. (NYSE:AVP) to get a better sense of its popularity.

Follow Select Medical Holdings Corp (NYSE:SEM)
Trade (NYSE:SEM) Now!

In today’s marketplace there are a lot of signals shareholders employ to analyze their holdings. A couple of the most innovative signals are hedge fund and insider trading interest. Our researchers have shown that, historically, those who follow the top picks of the elite hedge fund managers can outpace the S&P 500 by a healthy amount (see the details here).

Now, we’re going to take a gander at the new action encompassing Select Medical Holdings Corporation (NYSE:SEM).

How have hedgies been trading Select Medical Holdings Corporation (NYSE:SEM)?

Heading into Q4, a total of 23 of the hedge funds tracked by Insider Monkey were long this stock, a change of 5% from the second quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).

Of the funds tracked by Insider Monkey, North Tide Capital, managed by Conan Laughlin, holds the most valuable position in Select Medical Holdings Corporation (NYSE:SEM). North Tide Capital has a $141.3 million position in the stock, comprising 12.3% of its 13F portfolio. The second largest stake is held by Camber Capital Management, managed by Stephen DuBois, which holds a $46.9 million position; the fund has 4% of its 13F portfolio invested in the stock. Other hedge funds and institutional investors with similar optimism encompass Ken Fisher’s Fisher Asset Management, Eric Chen’s Antipodean Advisors and Israel Englander’s Millennium Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.